Drawing for ARTHROVISC

USPTO serial 79155264

ARTHROVISC

Reviewed by CopyMark Law Group

Reg. 4824366Status 707Registered
Filing date
Status date
Registration date
Oct 6, 2015
Examiner
MULLEN, MARK
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with ARTHROVISC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lindsay Kaplan

Lindsay Kaplan L. Kaplan Law8 North Frton Street, Suite 2002Kingston, NY 12401United States

Goods and services

ClassDescriptionStatusFirst use
003[ Cosmetics, namely, beauty masks, cosmetic kits comprising primarily of lotions, creams, and preparations for skin care, cosmetic creams, lotions for cosmetic purposes, cosmetic lotions, cosmetic preparations for skin care, pomades for cosmetic purposes, tissues impregnated with cosmetic lotions, cotton buds for cosmetic purposes, cosmetic kits for skin care comprising primarily of lotions, creams, and preparations for skin care, non-medicated preparations for skin care, namely, skin serum not for medical use, skin care preparations, namely, non-medicated skin serum, non-medicated stimulating lotions for the skin, anti-wrinkle cream for skin care, non-medicated anti-aging serum ]SECTION 71 - CANCELLED—
005Pharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontum growth and bone, organ or tissue regeneration; sanitary preparations for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes; pharmaceutical skin lotions; tissues impregnated with pharmaceutical lotions; medical dressings; surgical cloth tissues; medicated skin care preparations; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; preparations for medical purposes for cleaning the skin; solution kits for reconstituting allograft tissue; cells for medical or clinical purposes; all-purpose disinfectants; disinfectants for hygiene purposes; kits containing chemical reagents used for medical diagnosis; plant extracts, and human and animal tissue and cells in the nature of cultures, grafts and fresh cells, for medical and veterinary useACTIVE—
010Surgical apparatus and instruments for medical, dental or veterinary use; surgical and medical apparatus and instruments for use in dentistry, orthopedics, cosmetics, esthetics, general surgery, ophthalmology and mesotherapy; surgical and medical apparatus and instruments for use in cardiovascular, esthetic, cardiac, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; suture material; syringes for injections; cases fitted for medical instruments; receptacles for applying medicines, namely, bottles, jars, containers, canuale, syringes, tubes, infusion and injection devices for administering drugs, platelet-rich plasma, hyaluronic acid, and hydrogels; medical tubing for administering drugs, platelet-rich plasma, hyaluronic acid and hydrogels; syringes for medical use; cases fitted for use by surgeons or doctors; containers for storing tissue and biological samples; non-metallic containers for transporting and storing organs, tissue and cells for medical purposes; medical injection instruments; medical instruments, namely, surgical instruments for facilitating the identification, separation or removal of biological tissue; surgical and medical apparatus and instruments used in general surgery; medical apparatus used for taking blood; medical apparatus used for taking blood samples; apparatus used for separating blood components for medical purposes; medical instruments used for filtering blood and blood components; medical apparatus used for introducing pharmaceutical preparations into the human body; medical instruments, namely, surgical instruments for biological tissue; medical devices, namely, surgical instruments for biological tissues; medical apparatus intended for the preparation of platelet concentrate, glycosaminoglycan and polysaccharide hydrogelsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 9, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 9, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 9, 202671.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Feb 8, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 1, 2025ES71TEAS SECTION 71 RECEIVED—
Oct 6, 2024REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Sep 29, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 5, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 5, 2024EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Sep 5, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 5, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 5, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 9, 2024RNWLINTERNATIONAL REGISTRATION RENEWED—
Mar 27, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 27, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 19, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 19, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jan 19, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 19, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 24, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 18, 2022NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Sep 18, 2022C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Sep 17, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 6, 2022ES75TEAS SECTION 71 & 15 RECEIVED—
Oct 6, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 21, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 21, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 1, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 1, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 31, 2017DCPNCHANGE OF OWNER RECEIVED FROM IB—
Jul 8, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 2, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 2, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 9, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 9, 2016FIMPFINAL DISPOSITION PROCESSED—
Jan 6, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 6, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 21, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 17, 2015GPNXNOTIFICATION PROCESSED BY IB—
Jul 1, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 1, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 1, 2015NPUBNOTICE OF PUBLICATION—
Jun 17, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 15, 2015ALIEASSIGNED TO LIE—
May 28, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 27, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 26, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 26, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 20, 2014RFNTREFUSAL PROCESSED BY IB—
Nov 29, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 28, 2014RFRRREFUSAL PROCESSED BY MPU—
Nov 25, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 25, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 24, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2014DOCKASSIGNED TO EXAMINER—
Nov 21, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 20, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance